Ian J. Massey

Cardiff Metropolitan University — United Kingdom

Chemistry · Physical Sciences

18h-index1.3kcitations45works12.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Analytical Chemistry and Chromatography(8), COVID-19 Clinical Research Studies(5), Steroid Chemistry and Biochemistry(4), SARS-CoV-2 and COVID-19 Research(3), Iron Metabolism and Disorders(3)

Publications36 total

Seasonal variation in the associations between self-reported long-COVID symptoms and IL-6 signalling-related factors (particularly the rs2228145 variant of the IL-6R gene): A clinical study.
Cytokine·2025· 1 citedOpen Access
The effect of aortic morphology on peri-operative mortality of ruptured abdominal aortic aneurysm
European Heart Journal·2015· 81 citedOpen Access
Crossing Boundaries and Making Connections:an Integrated Approach to Assessment and Feedback
2011
Against the neutrality of form: the work of Mørten Lobner Espersen
University of Huddersfield Repository (University of Huddersfield)·2009Open Access
COMING UNSTUCK<BR> Teaching race and racism at KS2
Race Equality Teaching·2003
Revisiting the Solubility Concept of Pharmaceutical Compounds
Monatshefte für Chemie - Chemical Monthly·2001· 17 cited
AIRBUS AGAINST MERGER
Airfinance journal·1997
An indirect (derivatization) and a direct HPLC method for the determination of the enantiomers of ketorolac in plasma
Journal of Pharmaceutical and Biomedical Analysis·1996· 27 cited
Mutagenicity screening of reaction products from the enzyme-catalyzed oxidation of phenolic pollutants
Environmental Toxicology and Chemistry·1994· 29 cited
Characterization of reaction products from the enzyme catalyzed oxidation of phenolic pollutants
Water Research·1994· 116 cited
MUTAGENICITY SCREENING OF REACTION PRODUCTS FROM THE ENZYME-CATALYZED OXIDATION OF PHENOLIC POLLUTANTS
Environmental Toxicology and Chemistry·1994· 1 cited
Toxicity of Reaction Products from Enzymatic Oxidation of Phenolic Pollutants
Water Science & Technology·1992· 12 cited
Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.
British Journal of Clinical Pharmacology·1991· 40 citedOpen Access
Ketorolac Tromethamine Pharmacokinetics and Metabolism After Intravenous, Intramuscular, and Oral Administration in Humans and Animals
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy·1990· 94 cited
Simultaneous determination of ketorolac and its hydroxylated metabolite in plasma by high-performance liquid chromatography
Journal of Chromatography B Biomedical Sciences and Applications·1990· 33 cited
Development and characterization of a lyophilized dosage form of IL-1 beta.
PubMed·1990· 5 cited
ChemInform Abstract: Inhibitors of Cyclic AMP Phosphodiesterase. Part 4. Synthesis and Evaluation of Potential Prodrugs of Lixazinone (N‐Cyclohexyl‐N‐methyl‐4‐((1,2,3,5‐tetrahydro‐2‐oxoimidazo(2,1‐b)quinazolin‐7‐yl)oxy)butyramide, RS‐82856).
ChemInform·1989
Enhancement of Solubility, Dissolution Rate, and Oral Bioavailability of Rs-82856 by Complex Formation with Cyclodextrins
Drug Development and Industrial Pharmacy·1989· 7 cited
Inhibitors of cyclic AMP phosphodiesterase. 4. Synthesis and evaluation of potential prodrugs of lixazinone (N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazolin-7-yl)oxy]butyramide, RS-82856)
Journal of Medicinal Chemistry·1988· 25 citedOpen Access
Single intravenous dose and steady‐state oral dose pharmacokinetics of nicardipine in healthy subjects
Biopharmaceutics & Drug Disposition·1987· 15 cited
page 1 of 2Next →

Frequent Co-authors

Carl Djerassi(8), Michael D. Aitken(4), Phillip E. Heck(4), Ray Ashleigh(3), Nancy Chu(3), Ian T. Harrison(3), Edward J. Mroszczak(2), Matt Thompson(2), Robert J. Hinchliffe(2), Rachel E. Bell(2), Stanley Kushinsky(2), Anne Wu(2), Louise M. Ball(2), Irene Tsina(2), Michael C. Venuti(2), John Bruno(2), Arthur M. Strosberg(2), Leo Gu(2), Han-Meng Chiang(2), John H. Fried(2)